How many Neurizon Therapeutics shares are in issue?
Neurizon Therapeutics has 395,013,669 shares in issue.
What is the market cap of Neurizon Therapeutics?
The market capitalisation of Neurizon Therapeutics is AUD 73.08 M.
What is the 1 year trading range for Neurizon Therapeutics share price?
Neurizon Therapeutics has traded in the range of AUD 0.175 to AUD 0.245 during the past year.
What is the PE ratio of Neurizon Therapeutics?
The price to earnings ratio of Neurizon Therapeutics is -9.28.
What is the cash to sales ratio of Neurizon Therapeutics?
The cash to sales ratio of Neurizon Therapeutics is 78.26.
What is the reporting currency for Neurizon Therapeutics?
Neurizon Therapeutics reports financial results in AUD.
What is the latest annual turnover for Neurizon Therapeutics?
The latest annual turnover of Neurizon Therapeutics is AUD 924k.
What is the latest annual profit for Neurizon Therapeutics?
The latest annual profit of Neurizon Therapeutics is AUD -7.67M.
What is the registered address of Neurizon Therapeutics?
The registered address for Neurizon Therapeutics is LEVEL 4, 96-100 ALBERT ROAD, SOUTH MELBOURNE, MELBOURNE, VICTORIA, 3205.
What is the Neurizon Therapeutics website address?
The website address for Neurizon Therapeutics is www.neurizon.com/.
Which industry sector does Neurizon Therapeutics operate in?
Neurizon Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector.
Register for real-time alerts, custom portfolio, and market movers
Hot Features
Premium
